Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.

Yet this has also been an optimistic time where due to how low the sector is can be seen as a buying opportunity. Many see the future of cannabis as where the gains will lie. Although most of the cannabis sector is not trading well the industry as a whole is thriving. The cannabis industry continues to grow and show progress. In recent earning reports, most companies were able to show stronger profits and company gains. Still, this has not added much momentum to the public sector.

So with this most shareholders are preparing for the future and waiting for the moment to take profits. Now is a good time to do your research and follow the sector as much as you can. With cannabis still, a fairly young developing industry things can change for the better at any time. Below are several marijuana stocks to watch in today’s stock market.

Marijuana Stocks For Your 2025 Watch List

1. Aurora Cannabis Inc. (NASDAQ:ACB)
2. SNDL Inc. (NASDAQ:SNDL)
3. Cronos Group Inc. (NASDAQ:CRON)

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis derivative products in Canada and internationally. It has been some time since the company has released news.

Yet back on February 20th, 2025 the company announced the company’s extended pastille offerings in Australia. This development marks another meaningful step in Aurora’s deep commitment to offering patients premium medical cannabis products.

SNDL Inc.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. In recent news, the company announced its Q4 2024 and full-year earnings.

Highlights And Key Mentions

• Net revenue for the fourth quarter of 2024 was $257.7 million, and $920.4 million for the full year of 2024,
• Gross profit also reached new records, with $68.8 million in the fourth quarter of 2024, and $240.3 million for the full year.
• Gross margin (1) of 26.7% in the fourth quarter of 2024 and 26.1% for the full year are also new records.
• Operating loss was $(76.1) million for the fourth quarter of 2024, driven by a negative valuation adjustment of the SunStream portfolio of $(65.7) million.
• Free cash flow (1) was positive both in the fourth quarter of 2024, at $11.6 million, and for the full year, at $8.9 million.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany.

Recently the company announced the appointment of Anna Shlimak as CFO. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm.

[Read More] March 2025’s Top Cannabis Stocks: Key Players in the Growing Market

Words From The Company

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team.

The post 3 Canadian Marijuana Stocks To Watch For Future Gains 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.

Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years, playing a key role in shaping the Company’s strategy, operational efficiencies, and engagement with the financial and investment community. During her tenure, she has led many strategic initiatives including cost optimization, revenue growth, and building Cronos’ corporate brand, which have positioned the Company for long-term success.

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team. With a deep understanding of our business and a proven track record of driving financial performance, operational efficiency and strategic growth, Anna is the ideal leader to help drive our financial strategy and next phase of growth.

Mr. Gorenstein continued, “I want to sincerely thank James for his contributions to Cronos. He played an important role in improving our finance functions and has worked to build a robust Finance team. His commitment to Cronos has been essential and I thank James for everything he’s contributed to the Company and wish him all the best in his future endeavors.”

Mr. Holm said, “I’m incredibly proud of what we’ve accomplished over the past two and a half years and look forward to watching the Cronos team continue to deliver strong results. Under Anna’s leadership, I’m confident the Company will continue to grow and lead the cannabis industry on a global scale.”

Ms. Shlimak said, “I am honored to step into the role of CFO and continue working alongside our talented teams. Cronos is committed to building exceptional cannabis brands and products that enhance experiences, and I am excited to lead our financial and strategic growth as we continue to expand and drive performance. As we enter the next phase of growth, I look forward to driving long-term value for our shareholders, employees, and consumers.”

About Anna Shlimak
Anna recently served as the Company’s Chief Strategy Officer and was responsible for managing and directing the organization’s corporate strategy, investor relations, communications, government affairs, and information systems departments. Prior to joining Cronos, Anna was the Head of Investor Relations at Quest Partners LLC, a research-driven alternative investment firm. Anna was responsible for business development, investor reporting, marketing, and communication initiatives for the fund. Before that, Anna held a range of roles at the New York Stock Exchange in both the New York and London offices. She received a Master of Business Administration from Columbia Business School and holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.

About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about transition plans with respect to the Company’s Chief Financial Officer role; the Company’s growth, industry leadership, success and financial strategy; long-term value for the Company’s shareholders, employees and consumers; and the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Media Relations Contact:
Emily Whalen
Communications
Tel: (416) 504-0004
media.relations@thecronosgroup.com

Investor Relations Contact:
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

The post Cronos Group Inc. (CRON) Appoints Anna Shlimak as Chief Financial Officer appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Most marijuana stocks rely on the success of legal operators and a few other variables to build stronger trading. However, the true cure for the volatile downtrend and uncertainty is better laws and regulations. This issue has been a problem that has yet to be solved since cannabis first became legal in the US. Investors in the public space operate differently than most, and when there is fear or doubt, it can hinder how the flow of cannabis investing can go.

Looking back, when news on reform or regulation issues were being improved and worked on, it created healthy trading. People want to feel safe and limit as much risk, but they also do not want to miss out by not taking one either. Cannabis stocks are that happy medium as they operate more so in gray space where speculation is key. Right now, with how things are looking, the future of the industry is where most investors believe they will see better paydays.

As companies continue to show strong earnings and growth initiatives like new dispensaries, products, and strategic partnerships. When a person sees that a business can thrive and remain profitable it gives hope. Below are some marijuana stocks to watch if you find an interest in cannabis investing.

Top Marijuana Stocks For Your Watchlist Today

1. Jushi Holdings Inc. (OTC:JUSH)
2. Cresco Labs Inc. (OTC:CRLBF)
3. Trulieve Cannabis Corp. (OTC:TCNNF)

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. On March 6th, the company released its Q4 and full 2024 yearly earnings.

Highlights And Key Mentions

Q4 2024

• Total revenue of $65.9 million
• Gross profit and gross profit margin of $25.4 million and 38.6%, respectively,
• Net loss of $12.5 million
• Cash, cash equivalents and restricted cash were $21.3 million as of quarter end
• Net cash flows provided by operations of $7.2 million

Full 2024 Year

• Total revenue of $257.5 million
• Gross profit and gross profit margin of $118.3 million and 45.9%, respectively
• Net loss of $48.8 million

Cresco Labs Inc.

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. Recently, the company announced it will operate Kentucky’s largest medical cannabis cultivation license.

The agreement entitles Cresco Labs to manage and operate a cultivation facility with up to 25,000 square feet of canopy. This is a significant milestone establishing Cresco Labs as one of only two operators of Kentucky’s coveted Tier 3 cultivation licenses.

[Read More] Marijuana Penny Stocks with Big Potential in March 2025

Words From The Company

“I look forward to showing Kentucky residents why Cresco Labs’ portfolio is the most popular choice in both medical markets like Pennsylvania and adult use markets like Illinois. The Cultivation License allows for the construction of a state-of-the-art cultivation facility with up to 25,000 square feet of canopy, enabling us to deliver the quality and scale we are known for,” said Charlie Bachtell, CEO of Cresco Labs.”

Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries as well as through home delivery.

In recent news, the company announced the appointment of Ryan Blust as Interim Chief Financial Officer. The Company has also retained the services of an executive recruitment firm.

[Read More] Best US Cannabis Stocks to Watch in March 2025 as the Industry Evolves

Words From Kim Rivers

“We thank Wes for his good work, particularly with his team implementing robust financial controls to meet Sarbanes Oxley requirements last year,” said Trulieve’s Chief Executive Officer Kim Rivers.”

The post 3 Marijuana Stocks To Watch This Month As Trading May Begin To Build appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the appointment of Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer and the departure of Wes Getman as Chief Financial Officer to pursue other opportunities, each effective March 6, 2025. The Company has also retained the services of an executive recruitment firm to commence a search for a new chief financial officer prepared to make strategic contributions to the Company.

“We thank Wes for his good work, particularly with his team implementing robust financial controls to meet Sarbanes Oxley requirements last year,” said Trulieve’s Chief Executive Officer Kim Rivers. “Ryan has been with Trulieve since 2018, providing valuable expertise and leadership throughout his tenure, including previously stepping into the role when called upon. We look forward to working closely with Ryan and the team during this transition.”

Mr. Blust has over 20 years of accounting and finance experience. Prior to joining the Company in September 2018, Mr. Blust served as the Controller at Vector Solutions, a software company. Mr. Blust also served as CFO for Honeycomb Company of America, an aerospace manufacturer, and as Assistant Controller for Marinemax, a retail boat company. He began his career in public accounting in 2004, serving with both Cherry Bekaert as well as Bobbitt, Pittinger & Company.

Mr. Getman’s departure is not based on any disagreement with the Company regarding accounting principles, practices or financial statement disclosures.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
X: @Trulieve

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-appointment-of-ryan-blust-as-interim-chief-financial-officer-302395330.html

SOURCE Trulieve Cannabis Corp.

The post Trulieve Cannabis Corp. (TCNNF) Appointment of Ryan Blust as Interim Chief Financial Officer appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States, today announced it will participate in the 37th Annual ROTH Conference in Dana Point, California, to be held on March 16-18, 2025.

The Company will conduct 1×1 meetings during the conference. Investors interested in scheduling a meeting with GrowGen management can request a meeting through ROTH MKM or email GrowGen@kcsa.com.

About GrowGeneration Corp:

GrowGen is a leading developer, marketer, retailer, and distributor of products for both indoor and outdoor hydroponic and organic gardening, as well as customized storage solutions. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Charcoir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. Incorporated in Colorado in 2014, GrowGen is the largest chain of specialty retail hydroponic and organic garden centers in the United States. The Company also operates an online superstore for cultivators at growgeneration.com, as well as a wholesale business for resellers, HRG Distribution, and a benching, racking, and storage solutions business, Mobile Media or MMI.

To be added to the GrowGeneration email distribution list, please email GrowGen@kcsa.com with GRWG in the subject line.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250304370426/en/

Contacts

KCSA Strategic Communications
Philip Carlson
Managing Director
T: 212-896-1233
E: GrowGen@kcsa.com

The post GrowGeneration Corp. (GRWG) to Participate in the 37th Annual ROTH Conference on March 16-18, 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the Third Tranche closing, the Investor acquired 7,562,447 common shares (the “Common Shares”) and 5,330,728 Class A preferred shares (the “Preferred Shares” and together with the Common Shares, the “Shares”) of the Company at a price of C$3.2203 per Share (the “Per Share Price”) for gross proceeds of USD$28,955,918.44 (equal to C$41,519,891)1.

“With all three tranches of the Jupiter private placement now funded, Organigram has approximately C$57.8 million to further invest from its Jupiter strategic investment pool after completing investments of C$21 million in Sanity Group and C$2.7 million in Open Book Extracts,” said Paolo De Luca, Chief Strategy Officer of Organigram. “Opportunities in the space have only improved with cannabis valuations at historically weaker levels and many cannabis and hemp companies unable to access cost-efficient growth capital despite fundamentally strong businesses. We look forward to continuing to roll out our international and differentiated product strategy supported by the Jupiter platform.”

As previously announced, most of the Investment is being used by Organigram to fund a strategic investment pool, named “Jupiter” (the “Jupiter Pool”). The Jupiter Pool was designed to accelerate Organigram’s international growth ambitions and targets investments both overseas and in the United States. All potential investments will undertake rigorous legal compliance and due diligence processes.

Early Warning Disclosure

Immediately following the closing of the Third Tranche, the Investor beneficially owned 40,134,389 Common Shares and 13,794,163 Preferred Shares, representing 30% of the issued and outstanding Common Shares and 100% of the Preferred Shares, in each case on a non-diluted basis.

As previously announced, the Investment was undertaken in three (3) tranches, each subject to the satisfaction of certain conditions. Under the first tranche (the “First Tranche”), which closed on January 23, 2024, 12,893,175 Common Shares were issued to the Investor at the Per Share Price. Under the second tranche (the “Second Tranche”), which closed on August 30, 2024, 4,429,740 Common Shares and 8,463,435 Preferred Shares were issued to the Investor at the Per Share Price.

Approval by the Company’s shareholders, clearance under the Competition Act (Canada), applicable stock exchange approval and certain other conditions to closing of each of the First Tranche, the Second Tranche and the Third Tranche were satisfied in connection with the closing of the First Tranche. The aggregate subscription price of the Shares acquired by the Investor as part of the First Tranche, the Second Tranche, and the Third Tranche was C$124,559,674.36.

Pursuant to the terms of the subscription agreement between the Investor and the Company dated November 5, 2023, as amended pursuant to an amending agreement dated December 20, 2023 (the “Subscription Agreement”), Shares issued in the First Tranche, the Second Tranche, and the Third Tranche were allocated between Common Shares and Preferred Shares, such that if the number of Common Shares owned by the Investor or its affiliates, associates, related parties and any joint actors would have exceeded 30% of the aggregate number of Common Shares issued and outstanding (the “30% Threshold”) after the closing of the applicable tranche, the Company issued to the Investor the greatest number of Common Shares issuable pursuant to such closing without exceeding the 30% Threshold, with the remainder of the Shares issuable as Preferred Shares (all as more specifically set forth in the Subscription Agreement).

The Preferred Shares are non-voting convertible preferred shares of the Company convertible at the option of the Investor without payment of any additional consideration (subject to the 30% Threshold). The Preferred Shares are convertible initially on a one-for-one basis into Common Shares, provided however that the conversion rate will increase at a rate of 7.5% per annum commencing from the initial date on which Preferred Shares are issued, until such time as the holders of Preferred Shares would beneficially own, or exercise control or direction over, directly or indirectly, with their respective affiliates, associates, related parties and any joint actors, after giving effect to the conversion of the Preferred Shares, 49.0% of the aggregate number of Common Shares issued and outstanding.

The Investor entered into the Subscription Agreement in furtherance of its strategic investment in the Company. The Investor intends to review its investment in the Company on a continuing basis and may, subject to the terms of the A&R Investor Rights Agreement (as defined below), and depending upon a number of factors, including market and other conditions, increase or decrease its beneficial ownership, control, direction or economic exposure over securities of the Company, through market transactions, private agreements, treasury issuances, exercise of options, convertible securities, derivatives, swaps or otherwise. Pursuant to the Subscription Agreement, unless otherwise consented to in writing by the Investor in advance, the Company is required to use one-half of the proceeds from each of the First Tranche and the Second Tranche for general corporate purposes, and one-half of the proceeds of each of the First Tranche and the Second Tranche, and all of the proceeds of the Third Tranche, to fund the Jupiter Pool, subject to adjustment in accordance with the terms of the Subscription Agreement. The Jupiter Pool is to be invested by the Company in accordance with the terms of reference provided for in the A&R Investor Rights Agreement.

Pursuant to the amended and restated investor rights agreement entered into between the Investor and the Company concurrently with the closing of the First Tranche (the “A&R Investor Rights Agreement”), the Investor has the right to nominate up to 30% of the board of directors of the Company (the “Board”), subject to the Investor maintaining certain share ownership thresholds. The Investor is entitled, subject to the terms and conditions of its nomination rights, to replace its nominee directors from time to time. In addition, the Investor has certain governance rights, so long as it maintains certain share ownership thresholds, including pre-emptive rights, top-up rights and customary registration rights. The Investor is permitted to engage with the Board regarding the Company’s business and prospects.

This press release is being issued, in part, pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, which requires an early warning report to be filed under the Company’s profile on SEDAR+ at www.sedarplus.ca containing additional information respecting the foregoing matters. You may also contact the Investor’s media centre at +44 (0) 20 7845 2888, Victoria Buxton at +44 (0) 20 7845 2012 or Amy Chamberlain at +44 (0) 20 7845 1124 to obtain a copy of the early warning report once filed.

Further details relating to the Investment can be found in the press release issued by the Company on November 6, 2023 and the Company’s management information circular dated December 20, 2023 (the “Circular”).

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada, and Motif Labs Ltd., a licensed cannabis processor.

Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Forward-Looking Information

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Circular, and the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

1 As determined using the average daily exchange rate published by the Bank of Canada on February 26, 2025 for converting Canadian dollars into U.S. dollars, being CAD$1.00 equals USD$0.6974.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250303096345/en/

The post Organigram Holdings Inc. (OGI) Closes Third Tranche of Previously Announced BAT Private Placement Investment appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

When looking for the top marijuana stocks to buy, we often look for what we feel are the best companies. Yet, all that is going on outside of the industry has had a direct impact on trading. Marijuana stocks have struggled for several reasons. One of the main contributors to this has been regulatory uncertainty. Still, many countries and states are grappling with how to approach legalization and taxation. This uncertainty has led to volatility in the market and has discouraged some potential investors.

Additionally, some companies have faced challenges with profitability due to high operational costs and fierce competition. When more players enter the space, it can erode investor confidence. For investors to see improvements in trading is crucial. However, the speculation is that the future is where the gains are held becuase of legislative concerns that need to be met.

A healthier market could mean greater returns on investment, making cannabis stocks more appealing. Moreover, for the cannabis industry as a whole, a positive trading environment could provide the needed capital for growth, innovation, and job creation, establishing a more sustainable and successful industry in the long run. As trading continues in 2025, this year still holds strong potential for publicly traded cannabis companies. Below are several marijuana stocks to watch as the market could change for the better in the near future.

Top Marijuana Stocks To Watch Now In 2025

1. Planet 13 Holdings Inc. (OTC:PLNH)
2. Verano Holdings Corp. (OTC:VRNOF)
3. Glass House Brands Inc. (OTC:GLASF)

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. 

In recent news, the company announced a partnership to co-brand, package, and produce premium cannabis products for legendary boxing champion Mike Tyson. As well as wrestling icon Ric Flair and multi-platinum artist Future.

Words From The Company

“We are excited to continue to expand our celebrity-based universe, bringing the biggest names in entertainment and sports to life through top-tier cannabis products,” said Lee Fraser, Chief Administrative Officer of Planet 13.”

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. On February 27th the company released its Q4 earnings.

Fourth Quarter 2024 Financial Highlights

• Revenues, net of Discounts, of $218 million, a decrease of 8% year-over-year, and an increase of 1% versus the prior quarter.
• Gross profit of $108 million or 49% of revenue.
• SG&A expense of $84 million or 38% of revenue.
• Net loss of $(273) million or (125)% of revenue.
• Adjusted EBITDA1 of $63 million or 29% of revenue.
• Net cash provided by operating activities of $44 million.
• Capital expenditures of $14 million.

[Read More] Top Ancillary Cannabis Stocks to Watch in March 2025: Industry Leaders for Growth

Glass House Brands Inc.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

During the 2nd week of February 2025, the company reported its most recent earnings.

[Read More] 3 Marijuana Stocks To Buy During Inside Of A Downtrend

Highlights And Key Mentions

• We anticipate that Full Year 2024 Revenue will be a record high $200 to $202 million, up 25% year-over-year at the midpoint of updated guidance
• We expect Q4 Revenue to be in the range of $52 to $54 million, up 31% year-over-year at the midpoint of updated guidance
• We anticipate Q4 2024 cost of production will be below $115 per pound, and well below previous guidance of $125
• We expect fourth quarter adjusted EBITDA will be $7 to $9 million, versus prior guidance of $3 million to $5 million, and that operating cash flow will be $7 to $9 million versus prior guidance of breakeven to negative $1 million
• Year-end Cash and Restricted Cash is expected to be approximately $37 xmillion

The post 3 Marijuana Stocks For Better Investing In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the launch of Onward, a premium, non-alcoholic THC beverage offering a modern alternative for social occasions. These Farm Bill compliant beverages are available now online and coming soon to select Total Wine locations in Florida.

Available for purchase by consumers 21 years and older, Onward can be ordered via DrinkOnward.com and shipped directly to consumers in 36 states.
Available for purchase by consumers 21 years and older, Onward can be ordered via DrinkOnward.com and shipped directly to consumers in 36 states.
“Drawing on our vast experience in cannabis product development, Onward beverages powered by Trulieve are expertly crafted to align with evolving consumer preferences,” said Trulieve’s Chief Executive Officer Kim Rivers. “We are excited to introduce this innovative and federally compliant beverage line to those seeking a new and alternative form of refreshment.”

Onward beverages come in a variety of delicious flavors including Blueberry Mojito, Italian Spritz, Passionfruit Martini, Peach Bellini, and Sea Salt Margarita. These low-calorie, non-alcoholic cocktails are crafted in the USA using naturally derived THC and CBD with no artificial flavors, colors, or sweeteners offering consumers a new and natural way to sip, socialize, and savor the moment.

Available for purchase by consumers 21 years and older, Onward can be ordered via DrinkOnward.com and shipped directly to consumers in 36 states. Four packs of each flavor as well as a variety pack are coming soon for purchase at select Florida Total Wine stores in Clearwater, Fort Lauderdale, Jacksonville, Miami, Orlando, Tallahassee, Tampa, and St. Petersburg.

Onward beverages use a proprietary formulation and manufacturing process to provide a consistent experience in every can. When it comes to transparency and quality, we strive to set best practices for the industry and adult consumers. Lab testing for Onward beverages is conducted for each batch at final formulation and results can be found online at COA Testing.

For more information, please visit Drinkonward.com/ or follow us on Facebook, Instagram, and X at @DrinkOnward.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
X: @Trulieve

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-launch-of-onward-a-premium-thc-beverage-302385626.html

SOURCE Trulieve Cannabis Corp.

The post Trulieve Cannabis Corp. (TCNNF) Announces Launch of Onward: A Premium THC Beverage appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Ascend Wellness Holdings, Inc. (“AWH,” “Ascend” or the “Company”) (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, has announced the grand reopening of its Detroit dispensary today, which will now serve recreational adult-use consumers. This marks Ascend’s 38th dispensary within its seven-state footprint, and the Company’s eighth dispensary in Michigan with additional locations in Ann Arbor, Battle Creek, Grand Rapids, East Lansing, and Morenci.

To celebrate the reopening, Ascend invites customers to join in the grand opening festivities on Friday, February 28th. Customers will have the opportunity to explore the dispensary, meet with the local budtender team, and learn more about the Company’s wide selection of product offerings. The grand opening will kick off with a ribbon cutting at 8:45am, followed doors opening at 9:00am with vendor pop-ups, in-store promotions, and doorbuster deals. The revamped Detroit dispensary features a modernized showroom with seven points of sale to ensure seamless shopping. Customers can explore a curated selection of top-shelf flower through a deli-style experience, Ascend’s first in Michigan. Orders can be placed in-store and online, with delivery options coming soon.

“Consumers are looking for the best-in-class Michigan brands, affordable products, and innovative retail experiences,” said David Gacom, Chief Commercial Officer at Ascend. “As the state moves towards becoming the nation’s largest regulated market, we are prepared to meet these evolving consumer needs. “Ascend is committed to supporting the local communities in which we serve and we look forward to welcoming recreational customers at our newly re-opened dispensary in Detroit.”

Ascend customers can also join the free Ascenders Club, where purchases and in-store deals become even more rewarding. Customers can sign up in-store or online at www.letsascend.com.

Ascend Detroit is located at 24363 W. Grand River Ave. Detroit, MI 48219, and will be open from 9AM – 9PM Monday through Sunday. For more information about Ascend and its dispensaries, visit www.awholdings.com.

About Ascend Wellness Holdings, Inc.
AWH is a vertically integrated operator with assets in Illinois, Maryland, Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania. AWH owns and operates state-of-the-art cultivation facilities, growing award-winning strains and producing a curated selection of products for retail and wholesale customers. AWH produces and distributes its in-house Common Goods, Simply Herb, Ozone, Effin’, and Royale branded products. For more information, visit www.awholdings.com.

Cautionary Note Regarding Forward-Looking Information
This news release includes forward-looking information and statements, which may include, but are not limited to, the plans, intentions, expectations, estimates, and beliefs of the Company. Words such as “expects”, “continue”, “will”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking information and statements. Without limiting the generality of the preceding statement, this news release contains forward-looking information and statements concerning the Company’s current projections and expectations about future events and financial trends and the timely receipt of all required regulatory approvals. We caution investors that any such forward-looking information and statements are based on certain assumptions and analysis made by the Company in light of the experience of the Company and its perception of historical trends, current conditions and expected future developments, and other factors management believes are appropriate.
Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Such factors include, among others, the risks and uncertainties identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and in the Company’s other reports and filings with the applicable Canadian securities regulators on its profile on SEDAR+ at www.sedarplus.ca and with the SEC on its profile on EDGAR at www.sec.gov. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information or statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ascend-wellness-announces-grand-reopening-of-detroit-dispensary-its-38th-retail-location-in-the-nation-on-february-28th-302386075.html

SOURCE Ascend Wellness Holdings, Inc.

The post Ascend Wellness Holdings, Inc. (AAWH) Announces Grand Reopening of Detroit Dispensary appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Investing in cannabis stocks inside of a volatile sector has its ups and downs. There is much to consider and watch for when building your portfolio. The more diversified your marijuana stocks portfolio is the better at being more profitable. It can be tricky at times to know when to enter and exit trade and which publicly traded cannabis companies. Some tips on this would be to do your research and look for certain factors. For example, check out any recent news or financials.

Getting a better understanding of the company’s mission and future goals can be a big help when looking for marijuana stocks to buy. If a company is not profitable this can also present trouble for how the company trades. So the more profitable the company can be the better the odds of seeing upward trading. Especially when the average trader is looking at a company’s current success.

Now this is important but so is the future and what it can turn into. This is because more seasoned investors feel cannabis stocks will see their biggest gains. The cannabis industry is still young and growing so what may occur in the future has yet to be seen. Nevertheless, there is a large amount of optimism that trading will get better over time. The marijuana stocks to watch below could be the winners you need to invest in.

Top Marijuana Stocks For Your Portfolio

1. Curaleaf Holdings, Inc. (OTC:CURLF)
2. Greenlane Holdings, Inc.(NASDAQ:GNLN)

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations.

On February 3rd the company announced the launch of the “Reef” flower brand in Florida.

Words From The CEO 2/3/25

Boris Jordan, Chairman and CEO of Curaleaf. “No matter your strain preference, the approachable design, delicious flavor profiles, and consistent quality will bring a fresh perspective to our cannabis community in the Sunshine State.”

[Read More] Here Is How Marijuana Stocks Are Impact By The Cannabis Industry

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, and Europe. It operates in two segments, Consumer Goods and Industrial Goods. Back on January 15th, the company announced it had regained compliance with Nasdaq Listing Rule 5605(c)(2). 

This rule requires Nasdaq-listed companies to maintain an audit committee consisting of three independent directors. Greenlane is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.

[Read More] Top U.S. Cannabis Stocks to Watch This Month: February 2025 Picks

Words From The CEO

“Michael will be a tremendous asset to the Board in its oversight of the Company’s long-term strategy,” said Barbara Sher, Chief Executive Officer for Greenlane.”

The post 2 Cannabis Stocks For Potential Market Movers This Year appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..